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Globoid cell leukodystrophy (GLD, GCL, Krabbe disease) is an autosomal recessively inherited disease caused by the deficiency of galactocerebrosidase (GALC), the lysosomal enzyme that degrades galactosylceramide, a major glycolipid component of myelin and myelinforming cells. 1 Hallmarks of the disease include progressive demyelination, severe gliosis, and the presence in the white matter of characteristic multinucleated cells (the globoid cells) that contain undegraded galactosylceramide. 1 Apoptosis of oligodendrocytes and the formation of multinucleated globoid cells is believed to result from accumulation of the toxic compound galactosylsphingosine (psychosine), also a GALC substrate. 2 The twitcher mouse (twi/twi) is a naturally occurring model of human Krabbe disease also resulting from a mutation in the Galc gene. The biochemical and neuropathological findings in twitcher as well as the clinical course of the disease closely resembles that observed in humans with GLD. 3 Twi/twi mice are clinically normal until 20 days of age; after this time they grow slower and develop typical neurological signs including tremors and hind leg weakness. Disease progression is rapid and the mice rarely survive beyond 40 days of age. 3 Since it closely mimics the human disorder, the twitcher mouse has become a valuable model not only to understand the pathogenesis of GLD, but also to develop strategies to correct the GALC deficiency. 3 Earlier attempts at bone marrow transplantation (BMT) were found to slow disease progression and to increase the lifespan of recipient twitcher mice up to 100 days. GALC activity was completely or partially restored in many organs, including brain, where a concomitant decrease in psychosine levels was reported. There was also evidence of remyelination in transplanted mice. Yet despite these encouraging results, BMT could not reverse the course of the disease and the mice still developed the characteristic neuropathology. [4] [5] [6] [7] [8] [9] [10] Following the cloning of GALC, we and others showed that it was possible to use recombinant retroviruses to restore enzyme activity in vitro in a variety of GALC deficient cells, including oligodendrocytes derived from the twitcher mouse. [11] [12] [13] [14] However, no in vivo use of retroviruses has been so far reported. Recombinant adenoviruses expressing the GALC cDNA have been injected into the brains of neonatal twitcher mice. Although slight clinical and neuropathological improvement occurred, the rapid progression of the disease could not be halted and survival was not greatly extended. 15 Transgenic rescue of the twitcher mouse was attempted using the human GALC cDNA driven by the mouse myelin basic protein promoter. 16 Despite very low levels of expression of the GALC transgene in brain, transgenic twi/twi mice showed significant improvement clinically and significant reduction of brain psychosine levels. They developed disease more slowly, and twi/twi mice homozygous for the transgene survived up to 66 days. These results were deemed quite encouraging since they showed that even very low levels of exogenously delivered GALC had beneficial effects. 16 In the present work, we succeeded in transgenically rescuing the twi/twi mouse using a human BAC clone containing the entire GALC gene. Unlike the abovedescribed transgenic strategy, which employed a heterologous promoter to drive GALC cDNA expression, this system uses the human GALC transgene driven by its own regulatory sequences and is therefore more likely to be expressed in the correct temporal and spatial pattern. Twi/twi/hGALC transgenic (tg) mice were phenotypically indistinguishable from normal mice and showed complete reversion of the severe neuropathology associated with the disease.
Results

Generation of twi/twi/hGALC transgenic animals
Blast searches of the databases of the National Center of Bioinformatics (NCBI) with the human GALC cDNA sequence as query identified a 171 kB BAC clone (RP11-11P10), which contained the entire human GALC coding sequences over 60 kB. Since it also contained about 20 kB of sequences upstream of the GALC exon 1, it was likely to contain the upstream regulatory sequences necessary for correct enzyme expression. Injection of the purified BAC DNA into zygotes yielded two transgenic founders (two of four births), of which only one transmitted the human GALC trangene to progeny. Offspring from this hGALCtg founder mouse were subsequently mated with twi/ þ mice and the resulting twi/ þ /hGALC tg animals were crossed again to twi/ þ mice. Genotyping of these latter crosses identified within the same litters animals that carried the hGALC tg in the twi/twi background in addition to animals with the other expected genotypes.
Rescue of twi/twi phenotype with the hGALC transgene Twi/twi animals are phenotypically indistinguishable from nonaffected animals in the first 20 days of life. However after this time, they grow more slowly, develop typical neurological signs and rarely live beyond 40 days. Twi/twi and twi/twi/hGALC tg animals (littermate or age matched) were monitored over time for signs of disease and compared to wild-type animals as well as to animals carrying the transgene in the þ / þ and twi/À background. Weights were recorded every other day as a parameter of development and progression of disease. The results for two representative animals/genotype (one for twi/twi) are shown in Figure 1a . As expected, after day 20 the twi/twi animal failed to gain weight and eventually died by day 40. In contrast, the twi/twi hGALC tg mice continued to grow and gain weight and were indistinguishable from the þ / þ and twi/ þ animals ( Figure 1a) . Animals carrying the hGALC transgene in the þ / þ and twi/ þ background gained weight as wildtype control mice, thus excluding any effect of the transgene per se on the animals' growth ( Figure 1a ). The striking difference in size and appearance between a twi/twi mouse and a twi/twi hGALC tg at 40 days of age is shown in Figure 1b .
The twi/twi hGALC tg mice developed none of the neurological signs characteristically seen in twitcher animals after day 20. A group of these transgenic mice have been maintained for more than a year without showing any sign of disease. Propagation of the rescued Transgenic rescue of Krabbe disease R De Gasperi et al twi/twi/hGALC line is straightforward since both the male and female mice were fertile and reproduced normally.
As mentioned above, the transgenic twi/twi animals did not show any overt signs of neurological impairment. For quantitative assessment of their locomotor performance the animals were scored for running time on a rotating rod (Rota-Rod) under increasing constant acceleration. Four animals/genotype were tested beginning at 35 days, a time when the twi/twi mouse is rapidly deteriorating clinically. 17 While twi/twi mice were too compromised to perform this test and fell off the rod shortly after being placed, run times of the twi/twi hGALC tg animals were consistently as good as those of nonaffected control mice including þ / þ (wild type), twi/ þ , þ / þ / hGALC tg and twi/ þ /hGALC tg animals ( Figure 1c ).
Cerebellar, cerebral and spinal cord white matter of twi/twi hGALC tg mice (40-52 days of age) were compared by electron microscopy to those of twi/twi at 38-40 days of age. Twi/twi mice exhibited the typical signs of demyelination (including the frequent occurrence of myelin debris and of large and medium-sized unmyelinated or thinly myelinated axons) apoptotic oligodendrocytes, and swollen dystrophic axons. 18 In spinal cord we found prominent inclusions in the perykaryal cytoplasm of ventral horn motor neurons (Figure 2, panel c) . By contrast, no evidence of myelin and neuronal pathology was observed in the transgenic rescued animals. Therefore, based on growth characteristics, Rota-Rod performance and absence of neurological signs or neuropathology the twi/twi/hGALC tg mice appeared to be 'cured' and were essentially indistinguishable in all these measures from wild type animals.
Expression of the human GALC transgene
To determine whether GALC expression from the human transgene matched the expression pattern of the endogenous mouse GALC we measured enzyme activity in homogenates prepared from brain and kidney of twi/twi/ hGALC tg mice as well as age matched twi/ þ , twi/twi, and þ / þ . GALC activity in the brain of two twi/twi/ hGALC tg animals was similar to that of the control brain (Table 1) . It was increased 10-fold over the residual activity measured in the twi/twi mouse and twice the activity in the twi/ þ . Therefore, the human transgene was not only expressed in brain, but also resulted in the levels of activity that were within the normal range for this tissue. 16 GALC activity was also determined in the kidney, the tissue in twi/twi mice where a significant storage of galactosylceramide has been observed. [19] [20] [21] In contrast to brain, GALC activity was not restored to normal levels in the kidney of twi/twi/hGALC tg mice and was only slightly increased (less than two-fold) over the activity in the twi/twi mouse kidney (Table 1) .
RT-PCR analysis was used to confirm that the increase in GALC activity detected in the twi/twi/hGALC tg mice was indeed derived from expression of the human transgene. Using human-specific GALC primers, a 345 bp fragment was amplified from total RNA isolated from the brain of twi/twi/hGALC tg but not of twi/twi or wild-type mice ( Figure 3a) . As a control, a mouse actin fragment was amplified in parallel from each of the above samples. An identical hGALC fragment could also be amplified from RNA derived from the kidney of twi/ twi/hGALC tg (Figure 3a) . This result suggests that the small increase in GALC activity observed in the kidney of these mice is not artifactual, but rather the result of transgene expression.
To determine whether the low levels of hGALC activity in the twi/twi/hGALC kidney had any impact on galactosylceramide storage, we isolated the neutral glycolipid fraction from these mice as well as from twi/ twi and wild-type animals. Aliquots of these fractions, normalized to the same amount of starting tissue (wet weight), were analyzed by TLC. Compared to the twi/twi, the amount of galactosylceramide in twi/twi/hGALC tg was greatly reduced. Under these same conditions, this glycolipid could not be detected in control tissue (Figure  3b ), indicating that storage was not completely cleared. This result thus provides additional evidence that hGALC enzyme is expressed and functional in kidney. It is also consistent with previous observations suggesting that only small amounts of enzyme are needed to provide beneficial effects. 16 Finally we examined the expression pattern of hGALC in the brain of the rescued animals using antibodies raised against a peptide contained in the 30 KDa subunit. 22 This analysis showed GALC staining of cells throughout the brain of the rescued mouse. An example of cerebellar staining is shown in Figure 2b where both cells in the white matter as well as Purkinje cell neurons contain reaction product. Staining of twi/twi sections showed only background signal (Figure 2a ). These studies thus verify the widespread expression of the human transgene as well as its expression in both neurons and glia.
Discussion
The twitcher mouse has long been recognized as an authentic model for human Krabbe disease. It has been and still is a very useful tool not only to better understand the biochemical and pathological basis of the disorder, but also to develop therapeutic strategies to correct the enzyme deficiency. Different approaches have been tried to deliver the missing GALC to the twitcher mouse; all have yielded some improvement in survival and in the neuropathology, but none has succeeded in reversing the course of the disease. Of particular interest to us was a transgenic approach using the human GALC cDNA driven by the mouse myelin basic protein promoter. 16 Since the main hallmark of the disease is myelin destruction, this promoter was thought to be well suited to drive GALC expression in oligodendrocytes, the cells that are most severely affected by the enzyme deficiency. However, only very low levels of enzyme were detectable in brain of the resulting transgenic twi/ twi mice. Nonetheless, these mice survived longer and showed some improvement in the neuropathology. Based upon these encouraging results, we decided to follow up on the transgenic rescue strategy, and to use instead a human BAC DNA clone that encoded the GALC gene. This clone contained all the GALC exonic and intronic sequences and was likely to contain all the upstream genetic elements necessary to correctly drive GALC expression. The hGALC gene was introduced into the twi/twi background by crossing hGALC tg mice Transgenic rescue of Krabbe disease R De Gasperi et al generated by pronuclear injection, with twi/ þ animals. The resulting twi/twi/hGALC tg mice showed normal growth and weight gain after day 20 and none of the neurological signs characteristic of the twitcher mouse. Their motor coordination, as judged by Rota-Rod testing, was similar to control mice. The GALC deficiency was fully corrected in the brain of these mice with enzyme activity reaching levels in the control range. Normal appearing myelin sheaths in brain and spinal cord and the absence of globoid cells further indicated that the transgenically delivered hGALC was correctly expressed and fully functional in the twi/twi mouse. Some 'rescued' mice have been maintained for more than a year without any sign of disease or distress. However, while GALC deficiency was corrected in the brain of transgenic twi/twi mice, this was not true in kidney, where enzyme activity was only slightly higher than in the twi/twi mouse. Detection of hGALC mRNA, however, indicated that the small increase in activity was derived from expression of the human transgene. This was further supported by analysis of the glycolipid profile, showing that the low amount of hGALC expression was physiologically significant, as it could partially clear the storage of galactosylceramide.
The failure to correct the GALC deficiency in kidney is rather puzzling, especially in view of the fact that brain activity was fully restored. One possible explanation is that the hGALC BAC clone we used did not contain the genetic elements necessary to achieve normal expression in the kidney. These elements could have been absent in the specific BAC clone used to make the transgene (due for example to cloning artifacts or size limitation), but normally present in the human gene. Alternatively, there may be differences between humans and mice in the way GALC expression is controlled in the kidney. It is noteworthy that unlike twitcher mice, no storage of galactosylceramide has been reported in the kidney of GLD patients, 18 a finding that is not yet fully explained and probably deserves further investigation in light of our results.
From a therapeutic point of view, however, failure to restore normal GALC activity in kidney did not seem to result in any adverse long-term health effects for the mice, some followed up to over 1 year of age. Since the most devastating pathological effects associated with GALC deficiency are confined to the CNS and PNS, from our data we can conclude that the BAC transgenic strategy employed here represents the first successful attempt at rescuing the twitcher mouse from disease. Although well-characterized BAC (and PAC clones) are becoming more available through the human genome project, our data represent one of the few examples of the use of such large DNA constructs to transgenically correct an inherited disease. These data open the possibility of using these BAC and PAC clones to devise novel gene therapy approaches not only for Krabbe disease but also for other inherited disorders.
Methods Animals
All protocols for animal husbandry, surgery and sacrifice were approved by the Mount Sinai School of Medicine Institutional Animal Care and Use Committee. The twitcher mutation (twi) was maintained on a C57Bl/6 background (Jackson Laboratories, ME, USA) and the colony was maintained by crossing twi/ þ males and females.
Generation of trangenic mice
The BAC clone RP11-11P10 containing the entire human GALC gene (hGALC tg) was obtained through Research Genetics. This BAC clone was propagated in Escherichia coli DH10 and the DNA was isolated as previously described. 23 Purified BAC DNA was diluted to 1 mg/ml in 10 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 30 nM spermine,70 nM spermidine, 0.1 M NaCl. About 1 pl was used for each microinjection into fertilized oocytes (about 200) obtained from C3B6 females. Transgenic founders (hGALC tg) were identified from DNA isolated from tail biopsies by PCR using primers pairs specific for exons 1, 8 and 16 of the human GALC gene. 24 To obtain twi/twi/hGALC tg animals, hGALC tg transgenic mice were mated with twi/ þ animals and the resulting transgenic twi/ þ /hGALC tg animals were crossed with twi/ þ animals. Genotypying for the human GALC transgene was performed in genomic DNA isolated from tail clippings by PCR using a primer pair specific for exon 8 of human GALC (5 0 -GGCTCATTATCCTGGA ACCC-3 0 and 5 0 -CATTGAATCTAGGCTGGAAGAAT-3 0 ). Genotyping for the twi allele was performed according to the PCR amplification method followed by EcoRV digestion as described. 25 
RNA analysis
Total RNA was isolated from brain and kidney with the guanidinium thiocyanate method. 26 In total, 1 mg of total RNA was reverse transcribed using the iScript reagents (BioRad), as described by the manufacturer. A 346 bp fragment spanning nucleotides 705-1050 of the human GALC cDNA 27 was subsequently amplified using 2 ml of the above cDNA as described. 28 
GALC assay
Freshly removed brain and kidney were homogenized in 10 vol of 50 mM Na phosphate buffer, pH 6.5 and GALC activity measured using tritium-labeled galactosylceramide. 29 
Glycolipid isolation
Neutral glycolipids were isolated from the kidneys of twi/twi, wild type and twi/twi/hGALC tg mice by chloroform/methanol (2:1 v/v) extraction followed by phase partitioning 30 and alkaline methanolysis. The extracts were resuspended at 1 ml/100 mg wet tissue weight and aliquots corresponding to 2 mg wet weight were analyzed by thin layer chromatograph using Silica Gel 60 plates (Merck). Plates were developed in chloroform/ methanol/water 65:25:4 (v/v/v) and the glycolipid bands visualized with the orcinol/sulfuric acid spray reagent.
Preparation of antibodies against GALC
Polyclonal antibodies recognizing the 30 kDa mature GALC subunit were raised in rabbits using the synthetic peptide CTGRKGSYPLPPKSQPF (spanning amino acids 455-469 of the human GALC; modified from Nagano et al 22 ) conjugated to keyhole limpet hemocyanin (CTG . The antibodies were subsequently purified by affinity chromatography through CTG-agarose.
Immunohistochemical analysis
Mice were perfused transcardially with 4% paraformaldehyde in phosphate-buffered saline (PBS); the brains were removed and sectioned with a Vibratome in 50 mm sections. Free floating sections were treated with 1% H 2 O 2 in 10% methanol/PBS to destroy endogenous peroxidase, blocked for 1 h with 3% normal goat serum, 0.3% Triton X-100 in Tris-buffer saline, pH 7.2 and incubated overnight at room temperature with affinity purified anti-GALC antibodies (1:50 dilution in blocking solution) followed by horse radish peroxidase (HRP)-conjugated anti-rabbit IgG (1:500 dilution) (Jackson Laboratories) for 2 h. Immunoreactions were visualized with diamino-benzidine.
Ultrastructural analysis
Tissues were processed for electron microscopy essentially as described. 31 Animal were perfused with 2% paraformaldehyde, 1% glutaraldehyde in 0.1 M Na phosphate buffer, pH 7.2 containing 0.2 mM CaCl 2 . The tissues were postfixed in OsO 4 and embedded in Epon with or withour prior staining with 2% uranyl acetate. The samples were examined using a JEOL 100CX electron microscope (Akashima, Japan).
Testing of motor coordination
All mice were maintained in the same holding room under conditions of 12h/12 h light/dark cycle, constant temperature of 211C and 45% relative humidity in 45 Â 15 Â 15 plastic cages with sand bedding. Food and water were available ad libitum and the cages were cleaned once a week. Learning and motor coordination were tested using a constant accelerating Rota-Rod system for mice (model 7650, Ugo Basile, Italy). Mice were tested twice per day at 2 h intervals starting from day 35 of age.
Accesion numbers
AC015473 for the homo sapiens BAC clone RP11-11P10 and NM_000153 for the homo sapiens GALC cDNA sequences.
